| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.3 | 6e-20 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-16 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-13 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-12 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-11 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.31 | 1e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |